HomeNutrition & Raw MaterialsFeedMycotoxins in Feed and Flour Production, Understanding the hidden threat

Mycotoxins in Feed and Flour Production, Understanding the hidden threat

 

By Asief Aliyar, Milling and Grain 

This article draws on insights from dsm-firmenich’s mycotoxin research programme and expert contributions from Sabine Masching, Anneliese Müller, Dr Jayaraman Krishnarajan and Ines Taschl. 

Mycotoxins remain one of the most persistent and underestimated challenges in feed and flour production. These toxic compounds, produced by fungi that infect cereal crops during growth and storage, pose significant risks to both animal health and human food safety. While severe contamination leads to clear clinical signs, it is the low-level, subclinical exposure that often causes the greatest economic damage – silently undermining performance without visible symptoms. 

The scale of the problem 

Mycotoxin contamination is rarely limited to a single toxin. Data from dsm-firmenich’s global survey program (January–September 2025) found that 82 percent of over 19,000 feed samples analysed contained more than one mycotoxin. These toxins can interact additively or synergistically, amplifying their negative effects even when each individual toxin is present at levels considered ‘safe.’ 

For millers, understanding regional contamination patterns is essential. Different climates favour different mycotoxin-producing fungi and staying informed through local survey data enables better sourcing decisions. Crops including wheat, barley, oats, maize and rye are all vulnerable, with maize being particularly susceptible to Fusarium species that produce fumonisins, deoxynivalenol (DON) and zearalenone (ZEN). 

The challenge of low-cost binders 

In response to mycotoxin risks, many producers turn to binders – feed additives designed to reduce the absorption of harmful mycotoxins in the gut. These fall into three main groups: inorganic (bentonites and zeolites), organic (yeast cell wall components) and activated materials (charcoal). 

The critical issue with many inexpensive binders is their lack of specificity. While they may bind some mycotoxins, they also adsorb essential nutrients – amino acids, vitamins and trace elements – making them unavailable to the animal. 

“When amino acids, vitamins and trace elements are adsorbed by unspecific binders in the gastrointestinal tract, they are no longer bioavailable to the animal,” explains Sabine Masching, Product Manager Mycotoxin at dsm-firmenich. “This leads to reduced feed efficiency, compromised immunity, slower growth and suboptimal production performance.” 

This nutrient loss is often hidden: feed formulations may meet nutritional specifications on paper, but if a portion of those nutrients is bound and rendered unavailable, the actual delivered value is diminished. This effect can be especially damaging in high-performance systems where nutrient density is carefully calculated. 

Testing by dsm-firmenich of over 300 substances, including mineral clays, organoclays, charcoals and yeast derivatives, revealed wide variability in binding capacity even within the same binder class. This inconsistency is a red flag for producers, as a product that underperforms even modestly may allow residual mycotoxins to pass through the gut and exert negative effects on animal health and productivity. 

Subclinical impact on poultry 

In poultry production, even low-level mycotoxin exposure can compromise health and nutrition in ways that are not immediately obvious. When birds consume mycotoxins, organs including the liver, kidney, gizzard and intestine can be damaged, compromising digestion, nutrient absorption and overall productivity. 

The effects are wide-ranging: 

  • Aflatoxins target the liver and suppress the immune system 
  • Ochratoxin A damages kidneys and increases water consumption 
  • T-2 toxin causes gizzard erosion and affects reproductive organs 
  • DON (vomitoxin) reduces feed intake and compromises eggshell quality 
  • Fumonisins impact immune function and bone development 

Importantly, mycotoxins often work synergistically – meaning one plus one can equal three. Even when individual mycotoxin levels appear acceptable, the combined effect of multiple toxins can significantly reduce performance. Necrotic enteritis and coccidiosis, often subclinical, can be linked to low-dose DON exposure at just three to four mg per kg in the diet, as the toxin reduces gene expression related to tight junction proteins, leading to ‘leaky gut.’ 

Poor immune response is common as mycotoxins affect the gut, which is critical for immune function. This reduces immune response to viral diseases and affects vaccine programmes, where vaccines will not work as effectively, leading to increased disease costs and susceptibility. 

Subclinical impact on pigs 

In pigs, subclinical mycotoxin exposure similarly erodes performance without obvious signs. Reduced average daily gain and feed efficiency are among the earliest economic consequences. Even at low levels, mycotoxins can increase gut permeability, alter villus morphology and weaken barrier function. This allows bacteria and endotoxins to translocate from the gut into the bloodstream, fuelling chronic low-grade inflammation. 

Reproductive performance is particularly affected by ZEN, which has estrogenic activity. Even at low levels, ZEN can disturb estrous cycles, delay puberty, lower conception rates and reduce litter sizes in gilts and sows. 

The need for effective testing 

For millers, a robust testing programme is essential. Mycotoxins are not evenly distributed within raw materials – ‘hot spots’ can occur, leading to inaccurate test results if proper sampling procedures are not followed. Regular sampling and testing are essential to maintain consistent quality. Proper sampling requires collecting incremental samples from multiple locations, with the minimum length of the sampling probe being two metres for storage facilities. 

Rapid tests provide quick results for main mycotoxins, allowing millers to take immediate action. Multi-mycotoxin analysis reveals the full picture of contamination, including masked and emerging mycotoxins. Storage conditions also significantly impact mycotoxin levels, with proper temperature control and moisture management helping to prevent mycotoxin development. 

Enzymatic detoxification: a precision approach 

Advances in biotechnology have enabled the development of specific enzymes capable of irreversibly degrading mycotoxins into harmless compounds within the gastrointestinal tract. Unlike general binders, these enzymes act through biotransformation, breaking down the toxin’s molecular structure and rendering it non-toxic. 

FUMzyme®, for example, catalyses the conversion of fumonisins into a far less toxic hydrolysed form. It is the first enzyme of its kind approved in both the EU and the US for use in pigs and other species. ZENzyme® cleaves ZEN into a product with significantly reduced estrogenic activity, effectively preventing its absorption into the bloodstream. Regulatory approval for ZENzyme® is currently pending in the EU and the US, with promising results already demonstrated in pigs. 

A holistic approach 

Effective mycotoxin control requires a multi-pillar approach, combining prevention, detection and biological detoxification. This layered defence ensures comprehensive protection even when complete toxin elimination from feed is impractical. 

Addressing subclinical mycotoxin exposure yields measurable returns. Producers who reduce toxin-related growth suppression and immune compromise can expect improved feed conversion and faster growth rates, better vaccine response and reduced medication costs, higher reproductive performance and litter consistency, and lower chronic inflammation and improved animal welfare. 

NEXT POSTS

Subscribe to our newsletter to get the latest news from industry

Newsletter Registration

DOWNLOAD OUR APP